Sona is an experienced patent litigator with numerous victories in claim construction, at summary judgment, and at trial. She has worked on a half-dozen Federal Circuit appeals, including the en banc Therasense case that created a new legal standard for the inequitable conduct doctrine. Her work spans a wide range of technology sectors, with a focus on Hatch-Waxman litigation and medical devices, and further includes cases involving chemicals, computer chips, telephonic systems, and consumer products. Sona has handled numerous multi-party litigations, has argued before the Multi-District Litigation Panel, and has defended witnesses overseas under the Hague Convention. Her prior work experience in the pharmaceutical industry enables Sona to advise clients on various patent issues with an understanding of how companies operate and an eye towards their business needs. Clients have included Becton Dickinson, Purdue Pharma, AstraZeneca, Pfizer, Nova Biomedical, Schering-Plough, Sanyo, and Oral B.
- Therasense, Inc. (Abbott Laboratories) v. Becton, Dickinson & Co. and Nova Biomedical Corp. (N.D. Cal.): Part of litigation team representing defendants in successful six-year patent suit against four different patents involving diabetes blood glucose monitors. Won summary judgments of non-infringement and/or invalidity on first two patents and summary judgment of no literal infringement on third patent. Won bench trial finding third patent invalid and unenforceable, and secured attorneys fees. Won jury trial finding fourth patent invalid and not literally infringed. Remand following en banc rehearing on inequitable conduct pending. All other issues affirmed on appeal.
- Purdue Pharma Products L.P. et al. v. Par Pharmaceutical, Inc. et al. (D. Del.): Part of litigation team representing plaintiffs in ANDA suit against generic drug manufacturer involving a 24-hour oral analgesic. Won on infringement and enforceability following bench trial. Affirmed on appeal.
- Multidistrict Litigation No. 2126: In re Tramadol Hydrochloride Extended-Release Tablets Patent Litigation (J.P.M.L.): Succesfully argued for plaintiffs before the Multidistrict Litigation Panel to consolidate patent cases involving 24-hour oral analgesic.
- Roche Diagnostics Operations, Inc. et al. v. Abbott Diabetes Care, Inc. et al. (D. Del.; Fed. Cir.): Part of litigation team representing defendant Nova Biomedical Corp. in patent suit involving diabetes blood glucose monitors. Won summary judgment dismissing all patent issues based on successful claim construction. Appeal pending.
- Sanyo Electric Co., Ltd. v. MediaTek, Inc. et al. (C.D. Cal.): Part of litigation team representing plaintiffs in patent suit involving chips for CD and DVD drives. Won summary judgment dismissing counterclaim patent based on successful claim construction. Settled.
- Purdue Pharma L.P. v. Endo Pharmaceuticals Inc. et al. (S.D.N.Y.): Part of litigation team representing plaintiffs in a successful nine-year patent litigation against multiple generic drug manufacturers involving an oral analgesic. Focused on antitrust issues. Defended foreign witnesses on patent liability issues under the Hague Convention.
- AstraZeneca Pharmaceuticals v. Mayne Pharma (USA) Inc. (S.D.N.Y.): Part of litigation team representing plaintiff against generic drug manufacturer in successful ANDA litigation involving an anesthetic. Won bench trial finding patents infringed, enforceable, and valid. Affirmed on appeal.
- Catheter Flushing LLC v. AngioDynamics et al. (D. Utah): Represented defendant Becton, Dickinson in multi-party patent litigation involving catheters. Settled.
- Purdue Pharma Products L.P. et al. v. Impax Laboratories, Inc. and related cases (D. Del.): Part of litigation team representing plaintiffs in ANDA suit against multiple generic drug manufacturers involving a 24-hour oral analgesic. Cases closed.
- Purdue Pharma L.P. et al. v. Watson Laboratories. Inc. et al. and related cases (S.D.N.Y.): Part of litigation team currently representing plaintiffs in ANDA suit against multiple generic drug manufacturers involving oral analgesic. Cases pending.
- King Pharmaceuticals, Inc. et al. v. Teva Parenteral Medicines, Inc. et al. (D. Del.): Part of litigation team currently representing plaintiffs in ANDA litigation involving automatic injector for epinephrine. Case pending.
- King Pharmaceuticals, Inc. et al. v. Sandoz Inc. (D. N.J.): Part of litigation team currently representing plaintiffs in ANDA litigation involving automatic injector for epinephrine. Case pending.
- Wyeth Holdings Corp. et al. v. Sandoz Inc. (D. Del.): Part of litigation team currently representing plaintiffs in ANDA litigation involving antibiotic. Case pending.
Full case list available upon request.
©1996-2012 Ropes & Gray LLP. All rights reserved.
|
|
Education
-
JD, University of Southern California, Gould School of Law, 1997; Senior Notes Editor, Interdisciplinary Law Journal
-
BS (Biochemistry), University of California, Los Angeles, 1992
Courts
- U.S. District Court for the Southern District of New York
- U.S. District Court for the Eastern District of New York
- U.S. District Court for the Northern District of California
- U.S. District Court for the Central District of California
- Federal Circuit Court of Appeals
- Supreme Court of the United States
Memberships & Affiliations
- New York Intellectual Property Law Association, Women in IP Law (co-chair)
|
|